[Sepsis with hemolysis due to a liver abscess in a 60-year-old male patient]

H Lang1, J J Schmidt2, H Wedemeyer1

  • 1Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland.

Der Internist
|January 3, 2022
PubMed

Insights

Clostridium perfringens sepsis, often fatal, can be treated. This case highlights successful interdisciplinary management of C. perfringens sepsis with liver abscess, including antibiotics and organ support.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Hepatology

Background:

  • Clostridium perfringens sepsis is a rare but frequently fatal condition.
  • Pre-existing Crohn's disease and immunosuppressive therapy can increase the risk of C. perfringens infection.
  • Bilioenteric anastomosis is a potential predisposing factor for C. perfringens sepsis.

Observation:

  • A patient with Crohn's disease and a bilioenteric anastomosis developed C. perfringens sepsis with a liver abscess.
  • The patient presented with severe complications including acute kidney failure (AKIN stage III), hemolysis, and rhabdomyolysis.
  • Acute liver failure secondary to sepsis was also observed.

Findings:

  • Successful treatment involved a multidisciplinary approach including antibiotics (clindamycin and penicillin G) and surgical drainage of the liver abscess.
  • Intensive medical care management included hemodialysis with high cut-off filters for acute kidney injury, hemolysis, and rhabdomyolysis.
  • Therapeutic plasma exchange was crucial in managing sepsis-induced acute liver failure.

Implications:

  • This case demonstrates that aggressive, interdisciplinary intensive care can lead to successful outcomes even in severe C. perfringens sepsis.
  • Early recognition and prompt management of risk factors, infection, and organ dysfunction are critical.
  • Highlighting the importance of considering rare pathogens in immunocompromised patients with complex gastrointestinal conditions.